Investigation into the use of phencyclidine in modelling the symptoms of schizophrenia - neurochemical and behavioural studies in the rat
Schizophrenia is a chronic, severely debilitating psychiatric disorder that affects up to 1 % of the population worldwide. The N-methyl-D-aspartic acid (NMDA) receptor antagonist phencyclidine (PCP) can produce a syndrome in normal healthy humans that closely resembles the positive, negative and cog...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.680433 |